Evaluation of choice of medicine for hair growth in practising hair implant surgeons- original research
Keywords:
Androgenetic alopecia, hair regrowth, vitamins, minoxidilAbstract
Aim The purpose of the present research was to assess the treatment effects of various pharmaceutical agents used by hair implant surgeons to induce hair growth in affected patients. Methodology this study, 500 patients we combined the use of antioxidants, iron, calcium, zinc, amino acids, and vitamins E, D, and C with minoxidil and finasteride to control hair loss, reverse miniaturization, and achieve new hair growth within 2-4 months with group I and II having male participants subjected to cyclic regimen and only minoxidil as well finasteride respectively whereas group II and IV had female participants also following cyclic as well as control regimen respectively. The patients were also followed clinically for 2 years and were observed to maintain their improvement. Results In Group I, the average improvement in density with cyclical medicine was 30% at 2 months and 52% at 4 months. The average improvement in caliber was 37% at 2 months and 47% at 4 months. In control Group II, density improved by an average of 2% at 2 months and 3.6% at 4 months. Caliber was unchanged in 44% of the patients.
Downloads
References
Paus R. Principles of hair cycle control. J Dermatol 1998;25:793–802.
Sperling LC, Mezebish DS. Hair diseases. Med Clin N Am 1998; 82:1155–69.
Price VH. Treatment of hair loss. N Engl J Med 1999;341:964–973.
Hamilton, J.B. Patterned loss of hair in man: Types and incidence. Ann. N. Y. Acad. Sci. 1951, 53, 708–728.
Paus, R.; Cotsarelis, G. The Biology of Hair Follicles. N. Engl. J. Med. 1999, 341, 491–497.
Rousso, D.E.; Kim, S.W. A Review of Medical and Surgical Treatment Options for Androgenetic Alopecia. JAMA Facial Plast. Surg. 2014, 16, 444.
Banka, N.; Bunagan, M.J.K.; Shapiro, J. Pattern Hair Loss in Men. Dermatol. Clin. 2013, 31, 129–140.
Yip, L.; Zaloumis, S.; Irwin, D.; Severi, G.; Hopper, J.; Giles, G.; Harrap, S.; Sinclair, R.; Ellis, J. Gene-wide association study between the aromatase gene (CYP19A1) and female pattern hair loss. Br. J. Dermatol. 2009, 161, 289–294.
Price VH, Menefee E, Strauss PC. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical solution, placebo, and no treatment. J Am Acad Dermatol 1999;41(5 pt 1):717–21.
Sawaya ME, Shapiro J. Androgenetic alopecia. New approved and unapproved treatments. Dermatol Clin 2000;18:47–61.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Olsen EA, Funicella T, Koperski JA, Tschen-Cabrera EH. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2001;47:377–85.
Price VH, Menefee E. Quantitative estimation of hair growth. I. Androgenetic alopecia: effect of minoxidil. J Invest Dermatol 1990; 95:683–7.
Rundegren T, Trancik RJ. Stabilization of hair loss with minoxidil topical solution. Presented at the Third Intercontinental Meeting of Hair Research Societies, Tokyo, Japan, June 13–15, 2001.
Kassimir JJ. Use of topical minoxidil as a possible adjunct to hair transplant surgery. J Am Acad Dermatol 1987;16:685–7.
Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol 1998;39:578–89.
Spencer, D.K. The Hormonal Effects of Diet on Hair Loss. In: The Bald Truth, Chapter 2. New York: Simon & Schuster Inc. 1998; 37-54.
Goodman & Gillman. The Pharmacological Basis of Therapeutics. 10th edition. 2005.
Diani, A.R., M.J. Mulholland, and K.L. Shull. Hair growth effects of oral administration of finasteride, a steroid 5-alpha reductase inhibitor, alone and in combination with topical minoxidil in the balding stump tail macaque. J Clin Endocrinol Metab. 1992; 74:345-350.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.